Tacsan, Jessel .
HRN: 26-24-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2024
CEFUROXIME 500MG (TAB)
11/18/2024
11/24/2024
ORAL
500 Mg
BID
Postpartum Prophylaxis; T/c UTI
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes